CIA
NXTM

Capital Impact Advisors’s NxStage Medical Inc. NXTM Stock Holding History

Capital Impact Advisors’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-49,897
Closed -$1.21M – 161
2017
Q4 		$1.21M Hold
49,897
– – 0.52% 104
2017
Q3 		$1.38M Buy
49,897
+17,729
+55% +$473K 0.62% 75
2017
Q2 		$806K Sell
32,168
-12,323
-28% -$305K 0.37% 139
2017
Q1 		$1.19M Buy
+44,491
New +$1.23M 0.48% 118

Other funds holding NXTM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
PCM
Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Impact Advisors's NXTM Position: Q1 2018 in Review

Capital Impact Advisors sold out of NxStage Medical Inc. (NXTM) in Q1 2018, closing a stake of 49,897 shares — an estimated $1.21M sold.

Capital Impact Advisors first reported a position in NXTM in Q1 2017 and held it in 4 quarters. The position peaked at $1.38M in Q3 2017. 168 funds tracked by Wall St. Rank hold NXTM as of Q1 2018.

  • Capital Impact Advisors reported no remaining NxStage Medical Inc. position as of Q1 2018 after selling out during the quarter.
  • Capital Impact Advisors sold 49,897 NxStage Medical Inc. shares in Q1 2018, an estimated $1.21M.
  • Capital Impact Advisors first reported a position in NxStage Medical Inc. in Q1 2017 and held it in 4 quarters.
  • Capital Impact Advisors's NxStage Medical Inc. position peaked at $1.38M in Q3 2017.
  • 168 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2018.

Based on Capital Impact Advisors's 13F filing for Q1 2018, filed 11 Apr 2018.